These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. An inactivated poliovirus vaccine using Sabin strains produced on the serum-free PER.C6® cell culture platform is immunogenic and safe in a non-human primate model. Bockstal V, Tiemessen MM, Achterberg R, Van Wordragen C, Knaapen AM, Serroyen J, Marissen WE, Schuitemaker H, Zahn R. Vaccine; 2018 Nov 12; 36(46):6979-6987. PubMed ID: 30314910 [Abstract] [Full Text] [Related]
7. Differences in Antigenic Structure of Inactivated Polio Vaccines Made From Sabin Live-Attenuated and Wild-Type Poliovirus Strains: Impact on Vaccine Potency Assays. Crawt L, Atkinson E, Tedcastle A, Pegg E, sIPV Study Group, Minor P, Cooper G, Rigsby P, Martin J. J Infect Dis; 2020 Feb 03; 221(4):544-552. PubMed ID: 30788503 [Abstract] [Full Text] [Related]
8. Immunity status of adults and children against poliomyelitis virus type 1 strains CHAT and Sabin (LSc-2ab) in Germany. Eggers M, Terletskaia-Ladwig E, Rabenau HF, Doerr HW, Diedrich S, Enders G, Enders M. BMC Infect Dis; 2010 Dec 09; 10():347. PubMed ID: 21143885 [Abstract] [Full Text] [Related]
16. Characterization and standardization of Sabin based inactivated polio vaccine: proposal for a new antigen unit for inactivated polio vaccines. Westdijk J, Brugmans D, Martin J, van't Oever A, Bakker WA, Levels L, Kersten G. Vaccine; 2011 Apr 18; 29(18):3390-7. PubMed ID: 21397718 [Abstract] [Full Text] [Related]
17. Novel hollow microneedle technology for depth-controlled microinjection-mediated dermal vaccination: a study with polio vaccine in rats. van der Maaden K, Trietsch SJ, Kraan H, Varypataki EM, Romeijn S, Zwier R, van der Linden HJ, Kersten G, Hankemeier T, Jiskoot W, Bouwstra J. Pharm Res; 2014 Jul 18; 31(7):1846-54. PubMed ID: 24469907 [Abstract] [Full Text] [Related]
18. A national reference for inactivated polio vaccine derived from Sabin strains in Japan. Shirato H, Someya Y, Ochiai M, Horiuchi Y, Takahashi M, Takeda N, Wakabayashi K, Ouchi Y, Ota Y, Tano Y, Abe S, Yamazaki S, Wakita T, sIPV Evaluation Group of NIID-Virology II. Vaccine; 2014 Sep 08; 32(40):5163-9. PubMed ID: 25090648 [Abstract] [Full Text] [Related]